Organon & Co.
OGN
$14.86
$0.412.84%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Revenue | -0.38% | 4.15% | -0.06% | 5.46% | 7.61% |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -0.38% | 4.15% | -0.06% | 5.46% | 7.61% |
Cost of Revenue | 1.90% | 7.68% | 4.38% | 14.66% | 16.75% |
Gross Profit | -2.08% | 1.76% | -3.00% | -0.10% | 1.67% |
SG&A Expenses | 20.93% | -21.56% | -3.10% | -0.92% | -17.31% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 7.48% | -7.38% | 0.16% | 5.59% | 0.75% |
Operating Income | -24.37% | 68.10% | -0.77% | 5.08% | 35.86% |
Income Before Tax | 24.04% | 158.75% | -7.48% | 0.43% | -6.31% |
Income Tax Expenses | 104.52% | -790.91% | 233.33% | -39.66% | -14,833.33% |
Earnings from Continuing Operations | -80.04% | 518.97% | -19.42% | 13.56% | 405.56% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -80.04% | 518.97% | -19.42% | 13.56% | 405.56% |
EBIT | -24.37% | 68.10% | -0.77% | 5.08% | 35.86% |
EBITDA | -17.40% | 56.66% | 1.12% | 6.21% | 32.75% |
EPS Basic | -80.20% | 514.46% | -20.04% | 12.98% | 403.06% |
Normalized Basic EPS | -39.33% | 220.14% | -2.32% | 10.37% | 75.79% |
EPS Diluted | -80.66% | 508.20% | -20.87% | 13.04% | 405.97% |
Normalized Diluted EPS | -39.63% | 218.36% | -2.58% | 9.99% | 75.81% |
Average Basic Shares Outstanding | 0.81% | 0.75% | 0.76% | 0.51% | 0.49% |
Average Diluted Shares Outstanding | 1.28% | 1.33% | 1.03% | 0.86% | 0.47% |
Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Payout Ratio | 4.08% | -0.84% | 0.32% | -0.16% | -0.80% |